Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul-Sep;21(3):195-208.
doi: 10.4103/HEARTVIEWS.HEARTVIEWS_143_20. Epub 2020 Oct 13.

Thrombosis Management and Challenges in COVID-19 Patients Presenting with Acute Coronary Syndromes

Rasha Kaddoura  1 , Amar M Salam  2   3
Affiliations
Review

Thrombosis Management and Challenges in COVID-19 Patients Presenting with Acute Coronary Syndromes

Rasha Kaddoura et al. Heart Views. 2020 Jul-Sep.

Abstract

Thrombotic complications in patients with coronavirus disease 2019 (COVID-19) infection have been increasingly recognized, particularly those affecting the cardiovascular system. Patients with COVID-19 infection can suffer from increased coagulopathy as well as myocardial injury. In this review, we discuss these complications with special focus on management challenges in patients with acute coronary disease based on the available evidence from published literature.

Keywords: COVID-19; SARS-CoV-2; Scute coronary syndrome; coagulopathy; myocardial injury; percutaneous coronary intervention; severe acute respiratory syndrome-coronavirus-2; thromboembolic disease.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Severity of illness categories
See this image and copyright information in PMC

References

    1. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135:2033–40. - PMC - PubMed
    1. Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection.A scoping review. Thromb Res. 2020;192:152–60. - PMC - PubMed
    1. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:2950–73. - PMC - PubMed
    1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782–93. - PubMed
    1. Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis. 2020 S0033-0620(20)30123-7. - PMC - PubMed